Modeling the impact of hepatitis C viral clearance on end‐stage liver disease in an HIV co‐infected cohort with targeted maximum likelihood estimation
DOI10.1111/biom.12105zbMath1419.62435OpenAlexW1501519563WikidataQ37637357 ScholiaQ37637357MaRDI QIDQ4979239
Mireille E. Schnitzer, Marina B. Klein, Erica E. M. Moodie, Robert W. Platt, Mark J. Van der Laan
Publication date: 17 June 2014
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: http://europepmc.org/articles/pmc3954273
longitudinal datasurvival analysisKaplan-Meiermarginal structural modelinverse probability of treatment weightingtargeted maximum likelihood estimationdouble-robust
Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50)
Related Items (2)
Uses Software
Cites Work
- Doubly Robust Estimation in Missing Data and Causal Inference Models
- Effect of breastfeeding on gastrointestinal infection in infants: a targeted maximum likelihood approach for clustered longitudinal data
- Implementing a class of structural change tests: an econometric computing approach
- Addendum to ``A new approach to causal inference in mortality studies with a sustained exposure period. Application to control of the healthy worker survivor effect
- Unified methods for censored longitudinal data and causality
- Multiple Imputation Methods for Treatment Noncompliance and Nonresponse in Randomized Clinical Trials
- Adjusting for Nonignorable Drop-Out Using Semiparametric Nonresponse Models
- Direct and Indirect Causal Effects via Potential Outcomes*
- A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect
- Multiple Imputation for Interval Estimation From Simple Random Samples With Ignorable Nonresponse
This page was built for publication: Modeling the impact of hepatitis C viral clearance on end‐stage liver disease in an HIV co‐infected cohort with targeted maximum likelihood estimation